Director Shalom Jacobovitz filed a Form 4 with the SEC on November 13, 2026, disclosing the grant of a stock option for 4,591 shares of Clene Inc. common stock on November 12, 2026.

Key Highlights

  • Reporting person: Shalom Jacobovitz, Director of Clene Inc. (NASDAQ:CLNN)
  • Transaction date: November 12, 2026
  • Derivative acquired: Stock option for 4,591 shares of common stock, transaction code A
  • Exercise price: $4.00 per share
  • Vesting: Options vest immediately upon grant, according to the filing
  • Expiration date: November 11, 2036
  • Price of derivative security: $0

Jacobovitz Option Grant Under Clene's Amended 2020 Stock Plan

According to the Form 4 filed on November 13, 2026, Director Shalom Jacobovitz was granted a stock option on November 12, 2026, for 4,591 shares of Clene Inc. common stock. The filing indicates the option was granted under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.00 per share. The price of the derivative security at grant is reported as $0. The option carries an expiration date of November 11, 2036.

The filing's explanation of responses states: "This option was granted on November 12, 2026 as an option for 4,591 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.00 per share. The options vest immediately upon grant." Following the reported transaction, Jacobovitz beneficially owns 4,591 derivative securities directly, with no shares reported in Table I covering non-derivative securities.

The Form 4 was filed by one reporting person and signed by Jerome T. Miraglia as power of attorney on November 13, 2026. No amendment date was indicated, and no deemed execution date was listed for the transaction.

What Was Disclosed

Clene Inc. Director Shalom Jacobovitz disclosed the acquisition of a stock option for 4,591 shares of common stock at $4.00 per share, granted November 12, 2026 under the Amended 2020 Stock Plan, vesting immediately, and expiring November 11, 2036.